Dr. Rayaz Ahmed
Director — Hematology & Bone Marrow Transplantation
Hematologist & BMT Specialist
198 verified reviews
198
Recent Consultations
About Dr. Rayaz Ahmed
Dr. Rayaz Ahmed is the Director of Hematology and Bone Marrow Transplantation at Max Super Speciality Hospital, Saket, New Delhi. He brings over two decades of clinical experience in adult and paediatric hematology, with sub-specialisation in stem cell transplantation, leukaemia, lymphoma, and benign hematological disorders.
After completing his MBBS at Pt. Ravi Shanker University, Raipur in 1999, Dr. Ahmed pursued MD in Pathology at Shivaji University, Kolhapur in 2003 — where he was awarded the University Gold Medal — and subsequently completed his DM in Clinical Hematology at Christian Medical College & Hospital, Vellore in 2010.
Prior to joining Max Saket, Dr. Ahmed served as Senior Consultant in the Department of Hematology at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, and as Associate Professor in the Department of Hematology at CMC Vellore. He has extensive experience in autologous, allogeneic (matched sibling), haplo-identical, and matched unrelated donor stem cell transplantation, and runs a busy unit treating leukaemia, lymphoma, multiple myeloma, aplastic anaemia, thalassemia and sickle cell disease.
Conditions Treated by Dr. Rayaz Ahmed
- Acute Myeloid Leukaemia (AML)
- Acute Lymphoblastic Leukaemia (ALL)
- Chronic Myeloid Leukaemia (CML)
- Chronic Lymphocytic Leukaemia (CLL)
- Hodgkin and Non-Hodgkin Lymphoma
- Multiple Myeloma
- Aplastic Anaemia
- Thalassemia (major)
- Sickle Cell Anaemia
- Hairy Cell Leukaemia
Areas of Interest
- Autologous stem cell transplantation
- Allogeneic stem cell transplantation (matched sibling donor)
- Haplo-identical stem cell transplantation
- Matched unrelated donor stem cell transplantation
- Treatment of aplastic anaemia
- Thalassemia stem cell transplantation
- Sickle cell disease management
- Acute and chronic leukaemia management
- Lymphoma chemotherapy and transplantation
- Multiple myeloma therapy
Qualifications
- MBBS — Pt. Ravi Shanker University, Raipur, Chhattisgarh, India, 1999
- MD (Pathology) — Shivaji University, Kolhapur, Maharashtra, 2003
- DM (Clinical Hematology) — Christian Medical College & Hospital, Vellore, Tamil Nadu, 2010
Work Experience
- Director — Hematology & Bone Marrow Transplantation, Max Super Speciality Hospital, Saket, New Delhi (Present)
- Senior Consultant — Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
- Associate Professor — Department of Hematology, Christian Medical College (CMC), Vellore
Certifications (1)
University Gold Medal in MD Pathology
Shivaji University, Kolhapur — 2003
Memberships (4)
- Indian Society of Hematology and Blood Transfusion (ISHBT)
- Indian Society of Medical and Paediatric Oncology (ISMPO)
- Indian Stem Cell Transplant Registry (ISCTR)
- American Society of Hematology (ASH)
Research Papers & Publications (10)
Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children
International Hematology Journal — —
Factors influencing adherence to imatinib in Indian chronic myeloid leukaemia patients: a cross-sectional study
International Hematology Journal — —
V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia
International Hematology Journal — —
The use of a fludarabine-based conditioning regimen in patients with severe aplastic anaemia — a retrospective analysis from three Indian centres
International Hematology Journal — —
Two novel missense mutations in iron transport protein transferrin causing hypochromic microcytic anaemia and haemosiderosis: molecular characterisation and structural implications
Blood Cells, Molecules and Diseases — —
Outcome of treatment with a low-cost protocol in adults with T-cell acute lymphoblastic leukaemia in a tertiary care centre in India
International Hematology Journal — —
Improved clinical outcomes of high-risk β-thalassemia major patients undergoing HLA matched related allogeneic stem cell transplant with a treosulfan-based conditioning regimen and peripheral blood stem cell grafts
Bone Marrow Transplantation — —
Fluorescence in situ hybridisation patterns of BCR/ABL1 fusion in chronic myelogenous leukaemia at diagnosis
Cancer Genetics — —
Molecular basis of Wiskott-Aldrich syndrome in patients from India
International Hematology Journal — —
Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukaemia
Cancer Chemotherapy and Pharmacology — —
Procedures
Frequently Asked Questions
Send your reports — including CBC, bone marrow biopsy, flow cytometry, cytogenetics and HLA typing if available — through Gaf Healthcare. We will arrange a video consultation with Dr. Ahmed within 48–72 hours so he can assess transplant suitability and outline a treatment plan before you travel.